| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Ramtin Agah is Chief Medical Officer at RNXT. Ramtin Agah's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.0M at current prices.
Historically, Ramtin Agah's trades have earned a strong insider score of 75/100 across 14 rated trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +9.7%.
Net of sales, the RNXT filings show accumulation of 222,165 shares.
Ramtin Agah has 22 Form 4 filings on record from August 2021 to April 2026, all as Chief Medical Officer at RenovoRx (RNXT), 2021–2026.
The 27 reported transactions were 15 open-market purchases, 8 option or other derivative awards, 3 gifts and 1 conversion.
Counted by filing, the open-market trades come to 12 purchases worth about $171K and no sales.
The largest open-market purchase was 21,000 shares of RNXT at an average $1.40 on June 5, 2025, about $29K. Twelve months later RNXT was down 38%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 10,000 | $1.00 | $9,975.00 | +1.3% | -4.9% | - | |
| Dec 31, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 9,795 | $0.86 | $8,423.70 | +1.3% | +20.2% | - | |
| Dec 30, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 205 | $0.83 | $169.33 | - | +22.3% | - | |
| Dec 16, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 12,000 | $0.85 | $10,200.00 | +1.6% | +15.5% | - | |
| Dec 5, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 10,000 | $0.96 | $9,600.00 | +1.3% | -12.7% | - | |
| Nov 24, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 22,000 | $0.80 | $17,600.00 | +3.0% | +14.8% | - | |
| Jun 5, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 21,000 | $1.40 | $29,400.00 | +2.9% | -10.7% | -37.7% | |
| Apr 15, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 15,000 | $0.90 | $13,500.00 | +1.4% | +55.6% | +9.5% | |
| Apr 11, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 20,000 | $0.80 | $16,000.00 | +1.9% | +73.6% | +27.6% | |
| Apr 9, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 30,000 | $0.81 | $24,399.00 | +2.9% | +56.6% | +17.8% |